What's Happening?
The U.S. beauty industry, led by the Personal Care Products Council (PCPC), is engaging with lawmakers to address key regulatory priorities, including MoCRA implementation, non-animal testing, tariff relief,
and OTC reform. The industry seeks to modernize FDA processes for sunscreen reviews and expand non-animal testing methods. Tariff relief efforts focus on protecting domestic operations and jobs, while state-level bans on ingredients pose challenges to a unified regulatory framework.
Why It's Important?
The beauty industry's advocacy highlights the need for regulatory consistency and modernization to support innovation and competitiveness. Non-animal testing and tariff relief are crucial for maintaining global standards and protecting U.S. manufacturing. The industry's efforts may influence future legislative decisions and impact the regulatory landscape for cosmetics and personal care products.
What's Next?
As Congress considers OTC drug user fee negotiations, the industry will continue to push for provisions that support non-animal testing and modern UV filter approval processes. The outcome of these discussions will shape the regulatory environment for beauty products.
Beyond the Headlines
The industry's focus on non-animal testing aligns with global trends towards ethical and sustainable practices. The advocacy for tariff relief underscores the importance of international trade agreements in supporting domestic industries.
